Global Defibrillator Market Opportunities and Forecast 2023-2030

Defibrillator Market Overview

Cardiovascular disease (CVD) is a leading cause of death and disability across the world.Attributable to this, the demand for defibrillators has raised, as these devices facilitate save the lives of patients at a high risk of pathology.
 
The prevalence of lifestyle diseases like hypertension, obesity, dyslipidemia, and diabetes, that are major risk factors for CVD, is additionally on the increase. there's a strong linear relationship between high pressure levels and therefore the risk of developing CVDs. In the US, around 70th of people UN agency have suffered from their 1st vessel stroke, their 1st attack, and UN agency have congestive heart failure, are reportable to own a pressure of over 140/90 pressure unit.
 
The rising geriatric population across the world is another key issue conducive to the increasing prevalence of CVD, as aging is related to progressive deterioration within the structure and performance of the heart and acts as a catalyst within the development of chronic diseases. Thus, with the expansion within the geriatric population across the world, the incidence of heart diseases is predicted to extend.
 
AEDs put in publically places are typically liable to failure because of issues touching on the battery, software, and hardware. Failure to perform medical aid may end up in delayed treatment or maybe death. Over the years, variety of defibrillators are recalled because of technical errors within the functioning of the device with relation to shock delivery, electrical problems, and hardware configuration. These defects could result in undesirable product performance and even the death of the patient in some cases. In 2018, the FDA, in conjunction with Philips, issued a recall notice for numerous models of the HeartStart MRx electronic device. The recall was caused by a defect within the gas discharge tube (GDT), that may lead to the malfunction of the electronic device. In 2021, Medtronic recalled the Evera, Viva, Brava, Claria, Amplia, Compia, and Visa ICDs and CRT-Ds because of the short battery life related to these devices.
 
Cybersecurity is another major concern within the defibrillators market. The new generation of implantable defibrillators is technologically advanced, granting remote knowledge transfer. The agency has raised issues relating to the hacking of those devices. Medtronic was the most recent company to face Associate in Nursing agency cybersecurity issue in 2023, as Medtronic’s wireless measure technology didn't have encoding or authentication safety.

Report Metric	Details
Market size available for years	2023–2030
Base year considered	2023
Forecast period	2024–2030
Forecast unit	Value (USD Million)
Segments covered	Grade, Application and Region
Regions covered	North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered	Medtronic ,Stryker Corporation ,Koninklijke Philips N.V. ,Asahi Kasei Corporation ,Boston Scientific Corporation , Abbott, Nihon Kohden , MicroPort ,BIOTRONIK ,CU Medical Systems .

The covid-19 Impact on Defibrillator Market:

Like several different industries, COVID-19 badly knocked the electronic and semiconductor trade. This new event has compact nearly 230 countries in exactly a couple of weeks, leading to the forced conclusion of producing and transportation activities at intervals and across the countries. This has directly affected the expansion of the sector. It's calculable that COVID-19 to depart over USD thirty billion impacts on the physics and semiconductor trade. The arena is majorly affected thanks to transport restrictions on major physics and semiconductor staple suppliers. However, the rising want for semiconductors in many industries can supply fast market recovery over the longer-term amount.
 
Defibrillator Market Segment Overview



Based on product type, the defibrillator market is defibrillator into implantable cardiovascular defibrillators and external defibrillators. The implantable cardiovascular electronic device (ICDs) phase is anticipated to dominate this market throughout the forecast period. the large share of this market segment the large attributed to the increasing prevalence of cardiovascular diseases and therefore the development of technologically advanced defibrillators.
 
Based on patient types, the defibrillator market is segmented into adult and pediatric. The adult patient phase phase accounted for the largest market share in 2020. The adult patients segment dominated the worldwide defibrillators market with a share of largest in 2020.
 
Based on end users, the defibrillators market is segmented into hospitals, clinics, and viscus centers; prehospital care settings; public-access markets; alternate care facilities; home care settings; and different end users. The hospitals, clinics, and viscus centers phase dominated the global defibrillators market, with a share of largest , in 2020.
 
Market Analysis, Insights and Forecast – By Product Type
·       Implantable Cardiovascular Defibrillator
·       External Defibrillator  

Market Analysis, Insights and Forecast – By  Patient Type
·       Adult
·       Pediatric

Market Analysis, Insights and Forecast – By  Application
·       Hospitals
·       Clinics and Cardiac centres
·       Pre-hospital care settings
·       Public access markets
·       Home care settings
·       Alternate care facilities
·       Other end users

Defibrillator Market Regional Overview

Region-wise, in terms of regions, On the basis of region, the defibrillator market is segmented into North America, Europe, Asia Pacific, latin america, and also the middle east & Africa. The Asia Pacific region the highest to register the highest growth during the forecast amount. The Asia Pacific is segmental into China, India, Japan, south korea, Australia, and also the remainder of Asia Pacific, as well as Asian nation, Taiwan, Singapore, and New zealand.

Defibrillator Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
 
Defibrillator Market Competitor overview

Some key developments and strategies adopted by manufacturers in the Defibrillator are highlighted below.
 
·       In 2020, Abbott received FDA approval for its next generation ICDs and CRT-Ds underneath the brand Gallant.  

Defibrillator Market, Key Players

·       Medtronic
·       Stryker Corporation
·       Koninklijke Philips N.V.
·       Asahi Kasei Corporation
·       Boston Scientific Corporation
·       Abbott
·       Nihon Kohden
·       MicroPort
·       BIOTRONIK
·       CU Medical Systems

Frequently Asked Questions (FAQ) :

Q1. What is the total CAGR expected to be recorded for the Defibrillator market during the forecast period?

Q2. Which segment is projected to hold the largest share in the Defibrillator Market?

Q3. What are the driving factors for the Defibrillator market?

Q4. Which Segments are covered in the Defibrillator market report?

Q5. Which are the prominent players offering Defibrillator ?